These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3567370)

  • 21. Increase of NK cell-mediated cytotoxicity of hairy cell leukemia patients after splenectomy.
    Bigda J; Myśliwska J; Baran V; Zoltowska A; Hellmann A
    Eur J Haematol; 1989 Jul; 43(1):78-9. PubMed ID: 2767244
    [No Abstract]   [Full Text] [Related]  

  • 22. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric study on phagocyte function and determination of in vitro natural killer (NK) cell cytotoxicity in hairy cell leukaemia (HCL). Comparison with values obtained following post-traumatic splenectomy (SP).
    Demeter J; Mihalik R; Pálóczi K; Benczur M
    Acta Paediatr Hung; 1988-1989; 29(1-2):219-20. PubMed ID: 3255408
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
    Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
    Demeter J; Pálóczi K; Lehoczky D; Benczúr M
    Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
    Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
    Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
    Wagner L; Goldstone AH; Worman CP
    Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
    Rossi E; Gualandi F; Lamparelli T; Repetto M; Nocera A; Spriano M; Occhini D; Ruggeri C; Vimercati R; Damasio EE
    J Exp Pathol; 1987; 3(4):593-601. PubMed ID: 3502652
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
    Kim YB; Chung TJ
    Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clear-cell carcinoma of the kidney in a patient with hairy-cell leukemia. Immunologic and epidemiologic considerations].
    Buffa G; Marino G; Cocimano V; Capaldi A; Torchio B
    Minerva Urol Nefrol; 1990; 42(4):231-4. PubMed ID: 2095639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results.
    Foon KA; Maluish AE; Abrams PG; Wrightington S; Stevenson HC; Alarif A; Fer MF; Overton WR; Poole M; Schnipper EF
    Am J Med; 1986 Mar; 80(3):351-6. PubMed ID: 3953613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
    Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
    Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].
    Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G
    Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of the response to B-cell growth factor (BCGF) of hairy cells from a patient under IFN-alpha therapy.
    Génot E; Mathiot C; Kolb JP
    Blut; 1987 Jul; 55(1):65-7. PubMed ID: 3496931
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells.
    Galvani DW; Nethersell AB; Cawley JC
    Leuk Res; 1988; 12(3):257-62. PubMed ID: 3163399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of interferon alfa-n1 in the treatment of hairy cell leukemia.
    Cawley JC; Bottomley JM; Worman CP
    Med Clin North Am; 1986 May; Suppl():37-9. PubMed ID: 3488481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
    Ozes ON; Klein SB; Reiter Z; Taylor MW
    Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR; Rosenthal DS; Ault KA
    Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.